101-200

101. Ikeda T, Yoshino H, Sugi K, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function

　after acute myocardial infarction: results of a collaborative cohort study. J Am Coll Cardiol 2006; 48: 2268-2274.

102. Salerno-Uriarte JA, De Ferrari GM, Klersy C, et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic

　cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol 2007; 50: 1896-1904.

103. Chow T, Kereiakes DJ, Onufer J, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic

　cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction

　Patients) trial. J Am Coll Cardiol 2008; 52: 1607-1615.

104. Costantini O, Hohnloser SH, Kirk MM, et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: Strategies using T-wave alternans to improve

　efficacy of sudden cardiac death prevention. J Am Coll Cardiol 2009; 53: 471-479.

105. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981;

　64: 235-242.

106. Breithardt G, Becker R, Seipel L, et al. Non-invasive detection of late potentials in man: a new marker for ventricular tachycardia. Eur Heart J 1981; 2:

　1-11.

107. Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged

　electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association and the American

　College of Cardiology. J Am Coll Cardiol 1991; 17: 999-1006.

108. Kanovsky MS, Falcone RA, Dresden CA, et al . Identification of patients with ventricular tachycardia after myocardial infarction: signal averaged

　electrocardiogram, Holter monitoring and cardiac catheterization. Circulation 1984; 79: 264-270.

109. Kuchar DL, Thorburn CW, Sammel L, et al. Prediction of serial arrhythmic events after myocardial infarction: signalaveraged electrocardiogram, Holter

　monitoring and radionuclide ventriculography. J Am Call Cardiol 1987; 9: 531-538.

110. Gomes JA, Winters SL, Stewart D, et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after

　myocardial infarction: based on the signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 1987; 10:

　349-357.

111. Gomes JA, Winters SL, Martinson M, et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of

　myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 1988; 13: 377-384.

112. Ozawa Y. Prospective study of late potentials to predict cardiac sudden death and ventricular tachycardias in patients with myocardial infarction

　surviving over 4 weeks. Jpn Circ J 1990; 154: 1304-1314.

113. 中山雅裕，江波戸美緒，真島三郎．心筋梗塞患者の致死性不整脈事故発生に対する加算平均心電図の意義（A prospective study）．心電図 1996; 16: 746-

　752.

114. El-Sherif N, Denes P, Katz R, et al. for the Cardiac Arrhythmi a Suppression Trial/Signal-Averaged Electrocardiogram

　(CAST/SAECG) Substudy Investigators: Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious

　arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995; 25: 908-914.

115. Bigger JT Jr: Prophylactic use of implantable defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft

　surgery. N Engl J Med 1997; 337: 1569-1575.

116. Buxton AE, Lee KL, Fisher JD, J, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter

　Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1182-1190.

117. Ikeda T, Sakata T, Takami M et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial

　infarction. A prospective study. J Am Coll Cardol 2000; 35: 722-730.

118. Gomes JA, Cain ME, Buxton AE, et al. Prediction of longterm outcomes by signal-averaged electrocardiography in patients with unsustained

　ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001; 104: 436-444.

119. Middlekauff HR, Stevenson WG, Woo MA, et al. Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic

　cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 1990; 66: 1113-1117.

120. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive

　cardiomyopathy. Circulation 1993; 87: 1083-1092.

121. Turrini P, Angelini A, Thiene G, et al. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol

　1999; 83: 1214-1219.

122. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk

　stratification. J Am Coll Cardiol 2001; 37: 1628-1634.

123. Akhtar M, Williams SV, Achord JL, et al. Clinical competence in invasive cardiac electrophysiological studies. A statement for physicians from the

　ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. Circulation 1994; 89: 1917-1920.

124. Nikolic G, Bishop RL, Singh JB. Sudden death recorded during Holter monitoring . Circulation 1982; 66: 218-225.

125. Schmidinger H, Weber H. Sudden death during ambulatory Holter monitoring. Int J Cardiol 1987; 16: 169-176.

126. Olhausen KV, Witt T, Pop T, et al. Sudden cardiac death while weging a Holter monitor. Am J Cardiol 1991; 67: 381-386.

127. Feruglio G, Rickards A, Steinbach K. Cardiac Pacing in the world: A survey of the state of the art in 1986. Pacing Clin Electrophysiol 1987; 10: 768-

　777.

128. Mandel WJ, Hayakawa H, Danzig R, et al. Evaluation of sino-atrial node function in man by overdrive suppression. Circulation 1971; 44: 59-66.

129. Jordan JL, Yamaguchi I, Mandel WJ. Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome. Circulation 1978; 57: 217-223.

130. Scheinman MM, et al. Electrophysiologic studies in patients with bundle branch block. Pacing Clin Electrophysiol 1983; 6 (5 Pt 2): 1157-1165.

131. Dhingra RC, et al. Significance of the HV interval in 517 patients with chronic bifascicular block. Circulation 1981; 64: 1265-1271.

132. Englund A, et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and

　without syncope. J Am Coll Cardiol 1995; 26: 1508-1515.

133. 遠藤康弘，笠貫宏，大西哲，他．ヒス束内ブロックの臨床的・電気生理学的検討およびその長期予後．呼吸と循環1986; 34: 43-49.

134. Englund A, et al. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. Pacing Clin Electrophysiol 1998; 21:

　1979-1987.

135. Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and cathter ablation procedures. Circulation 1995;

　92: 673-692.

136. Josephson ME. Cinical Cardiac Electrophysiology. Techniques and interpretation. 3rd Edtion. Lippiun coot Williams & Wilkins 2002.

137. Myerburg RJ, Kessler KM. Managementy of patients who survive cardiac arrest. Mod Concepts Cardiovasc Dis 1986; 55: 61.

138. Josephson ME, Hrowitz LN, Speilman SC, et al. Electrophygiologic and hemodynamic studies in patients resuscitated from cardiac arrest. Am J

　Cardiol 1980; 46: 948.

139. Swerdlow CD, Winkle RA, Mason JW, et al. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983; 308: 1436-

　1442.

140. Aizawa Y, Naitoh N, Kitazawa H, et al. Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia. unassociated with

　coronary artery disease. American J Cardiolog 1993; 72: 916-921.

141. Moss AJ, Hall J, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular

　arrhythmia. Multicenter automatic defibrillator Implantation trial investigators. N Engl J Med 1996; 335: 1933-1940.

142. Kron J, Hart M, Schual-Berke S, et al. Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting

　those at risk of sudden death. Chest 1988; 93: 85-90.

143. Grimm W, Hoffmann J, Menz V, et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated

cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998; 32: 739-745.

144. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an

　implantable defibrillator. J Am Coll Cardiol 1999; 33: 1964-1970.

145. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrohic cardiomyopathy. Prospective evaluation of a therapeutic

　strategy based on clinical, Holter, haemodynamic, and electrophysiological findings. Circulation 1992; 86: 730-740.

146. Miyajima S, Murata M, Aizawa Y, et al. Assessment of electrical instability in patients with hypertrophic cardiomyopathy. Cardiac Arrhythmias

　Current Topics 1986: 523-527.

147. Saumarez RC, Slade AK, Grace AA, et al. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study.

　Circulation 1995; 91: 2762-2768.

148. Elliott PM, Sharma S, Varnava A, et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

　J Am Coll Cardiol 1999; 33: 1596-1601.

149. Peters S, Peters H, Thierfelder L. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-

　cardiomyopathy. Int J Cardiol 1999; 71: 243-250.

150. Peters S, Reil GH. Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia. Eur Heart J 1995; 16: 77-80.

151. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301: 1080-1085.

152. Satoh M, Aizawa Y, Funazaki T, et al. Electrophysiologic evaluation of asymptomatic patients with the Wolff- Parkinson-White pattern. Pacing Clin

　Electrophysiol 1989; 12: 413-420.

153. Waldo AL, Akhtar M, Benditt DG, et al. Appropriate electrophysiologic study and treatment of patients with the Wolff-Parkinson-White syndrome. J

　Am Coll Cardiol 1988; 11: 1124-1129.

154. Montoya PT, Brugada P, Smeets J, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 1991; 12: 144-150.

155. Priori SG, Napolitano C, Gasparini M, et al. Schwartz PJ. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation

　syndrome: A prospective evaluation of 52 families. Circulation 2000; 102: 2509-2515.

156. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and

　ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105: 73-78.

157. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome

　and no previous cardiac arrest. Circulation 2003; 108: 3092-3096.

158. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;

　105: 1342-1347.

159. Brugada P, Geelen P, Brugada R, et al. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001;

　12: 1004-1007.

160. Gasparini M, Priori SG, Mantica M, et al. Programmed electrical stimulation in Brugada syndrome: how reproducible are the results? J Cardiovasc

　Electrophysiol 2002; 13: 880- 887.

161. Eckardt L, Kirchhof P, Schulze-Bahr E, et al . Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation

　at two ventricular sites with up to three premature beats. Eur Heart J 2002; 23: 1394-1401.

162. Atarashi H, Ogawa S, Harumi K, et al. Idiopathic Ventricular Fibrillation Investigators. Three-year follow-up of patients with right bundle branch block

　and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am

　Coll Cardiol 2001; 37: 1916-1920.

163. 藤木明．電気生理検査－手技と装置．「臨床心臓電気生理検査」．編著: 井上博，奥村謙，医学書院 2002: 9-27.

164. Bhandari AK, Shapiro WA, Mo r a d y F, e t a l . Electrophysiologic testing in patients with the long QT syndrome. Ciruclation 1985; 71:

　63-71.

165. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes wi th vent r icular ar rhythmias .

　Role of an electrophysiologic study in risk stratification. Eur Heart J 2003; 24: 1473-1480.

166. Gibbons RJ, Baldy GL, Beasley JW, et al. ACC/AHA Guidelines for Excercise Testing. A Report of the American College of Cardiology/American

　Heart Association Task Force on Practice Guidelines (Committee on Excercise Testing). J Am Coll Cardiol 1997; 30: 260-315.

167. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AfIA guidelines for the management of patients with acute myocardial infarction: a report of the

　American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

　Infarction). J Am Coll Cardiol 1996; 28: 1328-1428.

168. Pina IL, Balady GJ, Hansom P, et al. Guidelines for clinical exercise testing laboratories: a statement for health-care professionals from the

　Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation 1995; 91: 912-921.

169. Schlant RC, Friesinger GC II, Leonard JJ. Clinical competence in exercise testing: a statement for physicians from the ACP/ACC/AHA Task Force on

　Clinical Privueges in Cardiology. J Am Coll Cardiol 1990; 16: 1061-1065.

170. Bruce RA, Fisher LD. Unusual prognostic significance of exercise-induced ST elevation in coronary patients. J Electrocardiol 1987; 20 (suppl): 84-88.

171. Irving JB, Bruce RA, DeRouen TA. Variations in and significance of systolic pressure during maximal exercise (treadmill) testing. Am J Cardiol 1977;

　39: 841-848.

172. Kato K, Saito F, Hatano K, et al. Prognostic value of abnormal postexercise systolic blood pressure response: prehospital discharge test after

　myocardial infarction in Japan. Am Heart J 1990; 119 (2 Pt 1): 264-271.

173. Maki S, Ikeda H, Muro A, et al. Preaictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 774 -778.

174. Sadoul N, Prasad K, Elliott PM, et al. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic

　cardiomyopathy. Circulation 1997; 96: 2987-2991.

175. Isobe N, Toyama T, Taniguchi K, et al. Failure to raise blood pressure during exercise is a poor prognostic sign in patients with hypertrophic non

　-obstructine crdiomyopathy. Circ J 2003; 67: 191-194.

176. Podrid PJ, Graboys TB. Exercise stress testing in the management of cardiac rhythm disorders. Med Clin North Am 1984; 68: 1139-1152.

177. Graboys TB, Lown B, Podrid PJ. DeSilva R Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am

　J Cardiol 1982; 50: 437-443.

178. Saini V, Graboys TB, Towne V, et al. Reproducibility of exercise- induced ventricular arrhythmia in patients undergoing evaluation for malignant　

　ventricular arrhythmia. Am J Cardiol 1989; 63: 697-701.

179. Mason JW for The Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with

　Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular arrhythmias. N Eng J Med 1993; 329: 445-453.

180. Sumitomo N, Harada K, Nagashima M, et al . Catecholaminergic Polymorphic Ventricular Tachycardia in Chi ldren and Young Adul t s :

　Elect rocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70.

181. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An Update. Circulation 1993; 88:782-784.

182. Corrado D, Basso C, Thiene G, et al. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000; 83: 588-559.

183. Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349: 1064-1075.

184. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Eng J Med 1988; 318: 129-133.

185. Maron BJ, Shirani J, Poliac LC, et al. Roberts WC and Mueller FO. Sudden death in young competitive athletes: clinical , demographic, and

　pathlogical profiles. JAMA 1996; 276: 199-204.

186. Thiene G, Basso C, Corrado D. Is prevention of sudden death in young athletes feasible?. Cardiologia 1999; 44: 497-505.

187. Schwartz PJ, Priori SG, Spazzolini C, et.al Genotype-Phenotype correlation in the long QT syndrome gene specific triggers for life-threatening

　arrhythmias Circulation 2001; 103: 89-95.

188. Priori SG, Napolitano C, Schuwartz PJ. Low penetrance in the long QT syndrome: clinical impact. Circulation 1999; 99:529-533.

189. Roden DM. Long QT syndrome. N Engl J Med 2008; 358: 169-176.

190. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009 ; 120: 1761-1767.

191. Priori SG, Schwartz PJ, Napolitani C, et al. Risk statification in the Long-QT syndrome. N Eng J Med 2003; 348: 1866-1874.

192. Zareba W, Moss AJ, Locati EH, et al. International Long QT Syndrome Registry. Modulating effects of age and gender on the clinical course of long

　QT syndrome by genotype. J Am Coll Cardiol 2003; 42: 103-109.

193. Wilde AAM, Jongbloed RJE, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differntiate HERG-related (LQT2) patients from

　KVLQT1-related patients (LQT1). J Am CollCardiol 1999; 33: 327-332.

194. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92:

　2929-2934.

195. Dausse E, Berthet M, Denjoy I, et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol 1996; 28: 1609

　-1615.

196. Priori SG, Napolitano C, Cantu F, et al. Differential response to Na+ channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model

　mimicking the SCN5A and HERG defects present in the long-QT symdrome. Circ Res 1996; 78: 1009-1015.

197. Schwartz, PJ, Locati, E. The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J 1985; 6 Suppl D: 103.

198. Moss AJ, Zebra W, Kaufman ES, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human

　ethera-go-go-related gene potassium channel. Circulation 2002; 105: 794.

199. Shimizu W, Horie M, Takenaka K, et al. Mutation sitespecific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1

　form of congenital long QT syndrome; multicenter study in Japan. J Am Coll Cardiol 2004; 44: 117-125.

200. Chen Q, Kirsch GE, Zhang D, et al. Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic

　ventricular fibrillation. Nature 1998; 392: 293-296.

文献